A phase 1b dose-escalation/expansion study of BET inhibitor RO6870810 in patients with advanced multiple myeloma
- Resource Type
- article
- Source
- Blood Cancer Journal, Vol 11, Iss 9, Pp 1-3 (2021)
- Subject
Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282 - Language
- English
- ISSN
- 2044-5385